Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy
出版年份 2023 全文链接
标题
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy
作者
关键词
-
出版物
CLINICAL CANCER RESEARCH
Volume 29, Issue 10, Pages 1916-1928
出版商
American Association for Cancer Research (AACR)
发表日期
2023-03-15
DOI
10.1158/1078-0432.ccr-22-3291
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells
- (2022) Martin K. Bakht et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease
- (2022) Ning Zhao et al. CLINICAL CANCER RESEARCH
- Phase 1a/1b study of FOR46, an antibody drug conjugate (ADC), targeting CD46 in metastatic castration-resistant prostate cancer (mCRPC).
- (2022) Rahul Raj Aggarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
- (2021) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors
- (2020) Tom A. Bäck et al. EJNMMI Research
- PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
- (2020) Wallace Jones et al. Cancers
- A Prospective Trial of 68Ga-PSMA and 18F-FDG PET/CT in Nonmetastatic Prostate Cancer Patients with an Early PSA Progression During Castration
- (2020) Beihe Wang et al. CLINICAL CANCER RESEARCH
- Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET
- (2020) Sinan Wang et al. CLINICAL CANCER RESEARCH
- Preclinical evaluation of 213Bi-/225Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer
- (2020) Sangeeta Ray et al. JOURNAL OF NUCLEAR MEDICINE
- A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals
- (2019) Sai Kiran Sharma et al. NUCLEAR MEDICINE AND BIOLOGY
- Development of Targeted Alpha Particle Therapy for Solid Tumors
- (2019) Narges K. Tafreshi et al. MOLECULES
- The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrier
- (2019) R. M. de Kruijff et al. Scientific Reports
- Loss of PSMA Expression in Non-neuroendocrine Dedifferentiated Acinar Prostate Cancer
- (2018) Peter Bronsert et al. CLINICAL NUCLEAR MEDICINE
- Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer
- (2018) Jun Hao et al. EUROPEAN UROLOGY
- Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
- (2018) Rahul Aggarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- Salivary gland toxicity of PSMA Radioligand Therapy: relevance and preventive strategies
- (2018) Thomas Langbein et al. JOURNAL OF NUCLEAR MEDICINE
- Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
- (2018) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators
- (2018) Ján Kozempel et al. MOLECULES
- Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
- (2018) Michael R. McDevitt et al. Nature Communications
- Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma
- (2018) Sophie Poty et al. CLINICAL CANCER RESEARCH
- Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
- (2018) Martin K Bakht et al. ENDOCRINE-RELATED CANCER
- The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
- (2015) Shusuke Akamatsu et al. Cell Reports
- Efficient 1-Step Radiolabeling of Monoclonal Antibodies to High Specific Activity with 225Ac for -Particle Radioimmunotherapy of Cancer
- (2014) W. F. Maguire et al. JOURNAL OF NUCLEAR MEDICINE
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis
- (2012) Markus Essler et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody
- (2011) J Schwartz et al. PHYSICS IN MEDICINE AND BIOLOGY
- Targeting Prostate Cancer Cells In Vivo Using a Rapidly Internalizing Novel Human Single-Chain Antibody Fragment
- (2010) J. He et al. JOURNAL OF NUCLEAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search